GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand [...]
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand [...]
You say Trintellix, I say Brintellix: Why a drug name [...]
Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s [...]
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic [...]
Blueprint promotes two more execs to C-suite as it looks [...]
Viatris yanks one batch of diabetes med Semglee because of [...]
Merck scores a win in $1.4B insurance fight over devastating [...]
UCB buys rare disease drugmaker Zogenix for up to $1.9B, [...]
FDA extends decision dates on bluebird bio’s gene therapy drugs [...]
Inside the Catalent FDA citation said to trigger Novo Nordisk’s [...]